Press Release: ZetaChain: The Private Memory Layer for AI

Choose a language:

Globe NewsWire News Distribution Service

Details: Written by Globe NewsWire Press Releases; Category: Globe NewsWire News Distribution Service; Published: 01 June 2026; Created: 01 June 2026; Last Updated: 01 June 2026

Key takeaways: SAN FRANCISCO, June 01, 2026 (GLOBE NEWSWIRE) -- Spend six months teaching one AI how you work. The next week, a better model ships. You open a fresh window and start over from nothing.

Posted: 2026-06-01 22:00:00

Get Full News Story On GlobeNewsWire Press Release Service

More News From This Category
Press Release: Levi & Korsinsky Announces Investigation of Securities Claims Against Verra Mobility Corporation (VRRM)
Mon, 01 Jun 2026 19:07:42 +0000

NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- Investors holding Verra Mobility Corporation (NASDAQ: VRRM) shares watched up to 46% of their investment disappear on May 26, 2026, after the Company cut its FY-2026 revenue guidance by $135 million to $145 million following the termination of a major customer contract. Shareholders who lost money on…

Press Release: BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avanos Medical, Inc. (NYSE – AVNS), Global Business Travel Group, Inc. (NYSE – GBTG), LiveRamp Holdings, Inc. (NYSE – RAMP), Equity Residential (NYSE –
Mon, 01 Jun 2026 16:07:41 +0000

BALA CYNWYD, Pa., June 01, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Press Release: Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode
Mon, 01 Jun 2026 13:07:41 +0000

DENVER, June 01, 2026 (GLOBE NEWSWIRE) -- (www.247marketnews.com) – Eli Lilly (NYSE:LLY) has once again captured the attention of the oncology community after reporting remarkably strong Phase 3 results for Retevmo (selpercatinib) in early-stage RET fusion-positive non-small cell lung cancer.

Press Release: EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
Mon, 01 Jun 2026 10:07:38 +0000

SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helixé product line with the launch of the Regenixé iPSC-derived Skin Stem Cell Secretome Mask (“Regenixé Mask”),…

Related Bing News Results